Dr. V Mohan

Novo Nordisk India launches world’s first and only GLP-1 RA, Oral Semaglutide- a gamechanger in diabetes

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…

3 years ago

India has the Potential to Become World’s Diabetes Care Capital: Says Expert

Celebrating Blue Diwali – 2020 – World Diabetes Day for inculcating awareness about approx. 463 million adults (20-79 years) living…

4 years ago